Zotefoams Plc
-2.00 (-0.51%)
Share Name Share Symbol Market Type Share ISIN Share Description
Zotefoams Plc LSE:ZTF London Ordinary Share GB0009896605 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.00 -0.51% 388.00 381.00 395.00 390.00 387.00 390.00 29,006 16:35:12
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Chemicals 100.8 7.0 9.0 43.1 189

Zotefoams PLC Chair Succession

17/01/2023 7:00am

UK Regulatory (RNS & others)

Zotefoams (LSE:ZTF)
Historical Stock Chart

From Dec 2022 to Mar 2023

Click Here for more Zotefoams Charts.


RNS Number : 8885M

Zotefoams PLC

17 January 2023

Zotefoams plc

(the 'Company' or 'Group')

Chair Succession

17 January 2023 - Zotefoams (LSE: ZTF), a world leader in cellular materials technology, today announces details of changes to its Board of Directors (the 'Board').

In line with the provisions of the UK Corporate Governance Code, the term of office of the existing Chair of the Company, Steve Good, is due to end in 2023. Following an assessment of the Board's existing skillsets against those required to deliver the Company's strategy, a search process led by the Senior Independent Director and supported by Korn Ferry was initiated in mid-2022 to identify and appoint a new Chair.

The search has been successfully concluded and we are pleased to announce the appointment of Dr Lynn Drummond as an Independent Non-Executive Director and Chair Designate.

Lynn is currently Chair and Pro-Chancellor of the University of Hertfordshire and a Board mentor for Criticaleye. Previously, she was a Non-Executive Director with Venture Life Group plc, RPC Group plc, Infirst Healthcare, Shield Holdings AG, Allocate Software plc, Consort Medical plc and Alimentary Health Ireland. Lynn spent 16 years as a Managing Director within Investment Banking for Rothschild. Prior to Rothschild, Lynn worked in the Cabinet Office in London as Private Secretary to the Chief Scientific Advisor. She has also been Chairman of Trustees for Breast Cancer Haven and was on the University of Cambridge, Centre for Science and Policy Development Group. Lynn holds a Bachelor of Science Degree in Chemistry from the University of Glasgow and a PhD in Biochemistry from the University of London. She is a Fellow of the Royal Society of Chemistry and a Fellow of the Royal Society of Edinburgh.

Lynn will take over as Chair following Zotefoams' Annual General Meeting on 24 May 2023, at which point Steve will retire from the Board.

Douglas Robertson, Senior Independent Director, said: "On behalf of the Board, I would like to thank Steve for his significant contribution to the Zotefoams Group and, in particular, his leadership as Chair. We wish him the best in his future endeavours."

David Stirling, Group CEO, said: "I am delighted to welcome Lynn to Zotefoams. Lynn brings considerable knowledge across a number of functions and sectors, including a long and distinguished career in life sciences. She brings extensive and relevant quoted-company experience and expertise to the Group. I look forward to working with her as we focus on delivering the next phase of our growth strategy."

Lynn Drummond said: "Zotefoams is a pioneer in cellular materials with the purpose of creating optimal material solutions for the benefit of society. I look forward to working with the Board as we focus on delivering long-term, sustainable growth in the interests of all our stakeholders."

There is no further information which would require disclosure under LR9.6.13 of the Listing Rules of the Financial Conduct Authority.


 Zotefoams plc                +44 (0) 208 664 1600 
 David Stirling, Group CEO 
 Gary McGrath, Group CFO 
 IFC Advisory                 +44 (0) 203 934 6630 
 Graham Herring 
  Tim Metcalfe 
  Zach Cohen 

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology delivering optimal material solutions for the benefit of society. Utilising a variety of unique manufacturing processes, including environmentally friendly nitrogen expansion for lightweight AZOTE(R) polyolefin and ZOTEK(R) high-performance foams, Zotefoams sells to diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT(R) advanced insulation for demanding industrial markets. Zotefoams also owns and licenses patented microcellular foam technology to reduce plastic use in extrusion applications and for ReZorce(R) mono-material recyclable barrier packaging.

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky, USA, Brzeg, Poland (foam manufacture), Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA, Stilling, Denmark (microcellular foam technology) and Jiangsu Province, China (T-FIT).


AZOTE(R) , ZOTEK(R) , ReZorce(R) and T-FIT(R) are registered trademarks of Zotefoams plc.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.



(END) Dow Jones Newswires

January 17, 2023 02:00 ET (07:00 GMT)

1 Year Zotefoams Chart

1 Year Zotefoams Chart

1 Month Zotefoams Chart

1 Month Zotefoams Chart
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20230328 16:25:56